A nanoparticle-based COVID-19 vaccine elicited immune responses suggesting very potent and broad protection against SARS-CoV-2 in a preclinical study.
A nanoparticle-based COVID-19 vaccine elicited immune responses suggesting very potent and broad protection against SARS-CoV-2 in a preclinical study.